Concepedia

Lisanne M. Roelofsen

LM

Statistics

Publications

4

Citations

651

H-Index

4

Active since

2021

Affiliations

Oncode Institute(Current)

Leiden University Medical Center

University Hospital of Basel

The Netherlands Cancer Institute

Lisanne M. Roelofsen is an author at Oncode Institute specializing in oncology, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2021–2023

4

Publications

4

An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer

Paula Voabil, Marjolein de Bruijn, Lisanne M. Roelofsen et al. · Nature Medicine · 2021 · 369 citations

, , +14

Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy

Victoria S. Pelly, Agrin Moeini, Lisanne M. Roelofsen et al. · Cancer Discovery · 2021 · 244 citations · Full text

, , +17

Protocol for ex vivo culture of patient-derived tumor fragments

Lisanne M. Roelofsen, Paula Voabil, Marjolein de Bruijn et al. · STAR Protocols · 2023 · 24 citations · Full text

, , +13

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML

Dyantha I. van der Lee, Georgia Koutsoumpli, Rogier M. Reijmers et al. · Cancers · 2021 · 14 citations · Full text

, , +17

1–4 of 4